Signal active
Organization
Contact Information
Overview
Xampla is a cleantech company that creates plant protein material for commercial use. Its materials include microcapsules, beads, films, threads, and other structures made from plant protein with biodegradable, biocompatible, and no synthetic ingredients used for food, cosmetics, household products, animal feed, packaging, and medical applications.
About
Biotechnology, CleanTech, Plastics and Rubber Manufacturing
2018
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Xampla headquartered in Europe, operates in the Biotechnology, CleanTech, Plastics and Rubber Manufacturing sector. The company focuses on Biotechnology and has secured $1.5B in funding across 60 round(s). With a team of 11-50 employees, Xampla is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Xampla, raised $7.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
5
6
0
$25.4M
Details
4
Xampla has raised a total of $25.4M in funding over 4 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2020 | Seed | 2.5M | ||
2021 | Seed | 8.3M | ||
2023 | Early Stage Venture | 6.2M | ||
2024 | Early Stage Venture | 7.0M |
Investors
Xampla is funded by 33 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Xampla | - | FUNDING ROUND - Xampla | 7.0M |
Qemetica Ventures (Formerly Ciech Ventures) | - | FUNDING ROUND - Qemetica Ventures (Formerly Ciech Ventures) | 7.0M |
Xampla | - | FUNDING ROUND - Xampla | 7.0M |
Cambridge Angels group | - | FUNDING ROUND - Cambridge Angels group | 7.0M |
Recent Activity
There is no recent news or activity for this profile.